BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

398 related articles for article (PubMed ID: 25642449)

  • 1. Exploring gut microbes in human health and disease: Pushing the envelope.
    Sun J; Chang EB
    Genes Dis; 2014 Dec; 1(2):132-139. PubMed ID: 25642449
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The potential impact of gut microbiota on your health:Current status and future challenges.
    Sirisinha S
    Asian Pac J Allergy Immunol; 2016 Dec; 34(4):249-264. PubMed ID: 28042926
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Roles of Inflammation, Nutrient Availability and the Commensal Microbiota in Enteric Pathogen Infection.
    Stecher B
    Microbiol Spectr; 2015 Jun; 3(3):. PubMed ID: 26185088
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mechanistic links between gut microbial community dynamics, microbial functions and metabolic health.
    Ha CW; Lam YY; Holmes AJ
    World J Gastroenterol; 2014 Nov; 20(44):16498-517. PubMed ID: 25469018
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gut microbiome and type 2 diabetes: where we are and where to go?
    Sharma S; Tripathi P
    J Nutr Biochem; 2019 Jan; 63():101-108. PubMed ID: 30366260
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gut Dysbiosis in Animals Due to Environmental Chemical Exposures.
    Rosenfeld CS
    Front Cell Infect Microbiol; 2017; 7():396. PubMed ID: 28936425
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lack of Vitamin D Receptor Causes Dysbiosis and Changes the Functions of the Murine Intestinal Microbiome.
    Jin D; Wu S; Zhang YG; Lu R; Xia Y; Dong H; Sun J
    Clin Ther; 2015 May; 37(5):996-1009.e7. PubMed ID: 26046242
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Gut microbiota and immune crosstalk in metabolic disease].
    Burcelin R
    Biol Aujourdhui; 2017; 211(1):1-18. PubMed ID: 28682223
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interplay between the lung microbiome and lung cancer.
    Mao Q; Jiang F; Yin R; Wang J; Xia W; Dong G; Ma W; Yang Y; Xu L; Hu J
    Cancer Lett; 2018 Feb; 415():40-48. PubMed ID: 29197615
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hypothesis Testing and Statistical Analysis of Microbiome.
    Xia Y; Sun J
    Genes Dis; 2017 Sep; 4(3):138-148. PubMed ID: 30197908
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Connecting the immune system, systemic chronic inflammation and the gut microbiome: The role of sex.
    Rizzetto L; Fava F; Tuohy KM; Selmi C
    J Autoimmun; 2018 Aug; 92():12-34. PubMed ID: 29861127
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pathological and therapeutic interactions between bacteriophages, microbes and the host in inflammatory bowel disease.
    Babickova J; Gardlik R
    World J Gastroenterol; 2015 Oct; 21(40):11321-30. PubMed ID: 26525290
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Application of metagenomics in the human gut microbiome.
    Wang WL; Xu SY; Ren ZG; Tao L; Jiang JW; Zheng SS
    World J Gastroenterol; 2015 Jan; 21(3):803-14. PubMed ID: 25624713
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gut Microbiota: From Microorganisms to Metabolic Organ Influencing Obesity.
    Stephens RW; Arhire L; Covasa M
    Obesity (Silver Spring); 2018 May; 26(5):801-809. PubMed ID: 29687647
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modulation of type 1 and type 2 diabetes risk by the intestinal microbiome.
    Paun A; Danska JS
    Pediatr Diabetes; 2016 Nov; 17(7):469-477. PubMed ID: 27484959
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prebiotic effects: metabolic and health benefits.
    Roberfroid M; Gibson GR; Hoyles L; McCartney AL; Rastall R; Rowland I; Wolvers D; Watzl B; Szajewska H; Stahl B; Guarner F; Respondek F; Whelan K; Coxam V; Davicco MJ; LĂ©otoing L; Wittrant Y; Delzenne NM; Cani PD; Neyrinck AM; Meheust A
    Br J Nutr; 2010 Aug; 104 Suppl 2():S1-63. PubMed ID: 20920376
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Physiological patterns of intestinal microbiota. The role of dysbacteriosis in obesity, insulin resistance, diabetes and metabolic syndrome].
    Halmos T; Suba I
    Orv Hetil; 2016 Jan; 157(1):13-22. PubMed ID: 26708682
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of the gut microbiota on inflammation, obesity, and metabolic disease.
    Boulangé CL; Neves AL; Chilloux J; Nicholson JK; Dumas ME
    Genome Med; 2016 Apr; 8(1):42. PubMed ID: 27098727
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Microbe-microbe and host-microbe interactions drive microbiome dysbiosis and inflammatory processes.
    Proal AD; Lindseth IA; Marshall TG
    Discov Med; 2017 Jan; 23(124):51-60. PubMed ID: 28245427
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A discussion of the gut microbiome's development, determinants, and dysbiosis in cancers of the esophagus and stomach.
    Grover K; Gregory S; Gibbs JF; Emenaker NJ
    J Gastrointest Oncol; 2021 Jul; 12(Suppl 2):S290-S300. PubMed ID: 34422393
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.